Search Results 521-530 of 5952 for 搜索引擎在线咨询邮箱：lgooxc@hotmail.com
See the application selection process for Benefactor-Funded Research Established-Investigator Career Awards at Mayo Clinic's Center for Clinical and ...
Monoclonal antibodies, such as nivolumab and brentuximab vedotin, may interfere with the ability of cancer cells to grow and spread. Participation eligibility.
Monoclonal antibodies, such as nivolumab, may block cancer growth in different ways by targeting certain cells. Biological therapies, such as brentuximab ...
Probe-based Volumetric Laser Endomicroscopy (pVLE) of Endoscopic Mucosal Resection (EMR) Tissue in Patients With Barrett's Dysplasia · Overview · Participation ...
The purpose of this FIH study is to assess the safety and tolerability, effectiveness, pharnacokinetcs (PK), and pharmacodynamics (PD) of increasing dose levels ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Pathophysiology and etiology of edema in adults. https://www.uptodate.com/contents/search. Accessed Jan. 21, 2024. Smith CC. Clinical manifestations and ...
Collaborators. The Memory Disorders Laboratory collaborates with other research experts in dementia, imaging, neurology, psychiatry, pathology and sleep ...
The AURORA study will be conducted to confirm the efficacy and safety of cenicriviroc (CVC) for the treatment of liver fibrosis in adult subjects with NASH.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift to our 2025 Drive to Cure Cancer and transform the way cancer is treated and defeated.